Abscopal effects observed in cancer radiation therapy and oncolytic virotherapy: an overview

Drugs of Today
G Romano, I R Marino

Abstract

Immunoglobulin-mediated suppression of immune checkpoint pathways may lead to a considerable activation of host immune responses against malignancies. Substantial therapeutic benefits were reported among patients who participated in cancer immunotherapy clinical trials which utilized monoclonal antibodies against cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), programmed cell death protein 1 (PD-1) and programmed cell death 1 ligand 1 (PD-L1). In a subsequent stage, immune checkpoint inhibitors were used in various clinical trials in combination with other therapeutic agents, such as immunomodulatory factors, chemotherapeutics, oncolytic viruses and radiation therapy. Interestingly, local antitumor interventions based either on radiation therapy or oncolytic viruses resulted in systemic immune responses in a number of oncological patients. The elimination of untreated cancer tissues that may follow a localized therapeutic intervention was termed abscopal effect, which represents a major achievement in the field of cancer therapy.

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

Cancer Treatment and Research
Emily H Castellanos, Leora Horn
Zhonghua zhong liu za zhi [Chinese journal of oncology]
X R Zhu, L Z Zheng
Journal of Cellular Physiology
Sanam SadreddiniLeili Aghebati-Maleki
© 2022 Meta ULC. All rights reserved